Low-Grade Serous Cancer Research Catalogue
How to access research
Below is a list of low-grade serous cancer journal articles.
Members of the international low-grade facebook page (open to any woman with low-grade serous carcinoma) and our support group for carers/family/friends of low-grade serous women can also find the articles in the facebook group by going to “Files” and selecting “The Library”. On mobile devices “Files” is located under “… More”/”View Group Info”.
Learn more about research and how to interpret it.
10 Significant Studies
- Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
- Current status and future perspectives in low-grade serous cancer of the ovary
- Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions
- Does tumor grade infuence the rate of lymph node metastasis in apparent early stage ovarian cancer?
- Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
- Immunosuppressive microenvironment in low-grade serous ovarian carcinoma
- Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer
- Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
Reviews
- Current status and future perspectives in low-grade serous cancer of the ovary
- Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions
- Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy
- Low grade serous ovarian carcinoma: identifying variations in practice patterns
- Low-grade Serous Neoplasia of the Female Genital Tract
- Préservation de la fertilité, contraception et traitement hormonal de la ménopause chez les femmes traitées pour tumeurs malignes rares de l’ovaire : recommandations du réseau national dédié aux cancers gynécologiques rares (TMRG/GINECO)
- low-grade epithelial ovarian cancer: what a radiologist should know
- Low-grade epithelial ovarian cancer: a number of distinct clinical entities?
Clinical Research
Case Studies
- Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment
- Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
- Dramatic clinical response following dabrafenib and trametinib therapy in a T heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation
- Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with T metastatic low grade serous ovarian carcinoma
- Fine needle aspiration cytology of a nodal low-grade serous neoplasm: a case report of low-grade serous carcinoma arising from a serous borderline tumour with cyto-histological correlation
- First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma
- Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
- Low-grade ovarian serous carcinoma metastasis to the maxilla
- Low-grade serous carcinoma (mullerian/ovarian type) of the paratestis presenting as diffuse metastatic disease of unknown origin: Case report of an uncommon tumor with an unusual presentation
- Primary peritoneal low-grade serous carcinoma in a man: A case report and review of the literature
- Rare metastatic patterns after malignant transformation of serous borderline tumor of the ovary
- Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine
- Response to trametinib in recurrent low-grade serous ovarian cancer with T NRAS mutation- A case report
- Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer
Clinical Trials
- Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
Observational Research
- Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
- Does tumor grade infuence the rate of lymph node metastasis in apparent early stage ovarian cancer?
- Epidemiology of low-grade serous ovarian cancer
- Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma
- Increase in post-therapy tumor calcification on CT scan is not an indicator of response therapy in low-grade serous ovarian cancer
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- Obesity Is Associated With Worse Overall Survival in Women With Low-Grade Papillary Serous Epithelial Ovarian Cancer
- Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer
- Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study
- Pregnancy and oncologic outcomes of early stage low grade epithelial ovarian cancer after fertility sparing surgery: a retrospective study in one tertiary hospital of China
- Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- Stage II to IV Low-grade Serous Carcinoma of the Ovary Is Associated With a Poor Prognosis: A Clinicopathologic Study of 32 Patients From a Population-based Tumour Registry
- The clinical study of secondary cytoreductive surgery in the treatment of low grade serous ovarian cancer
- The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
- The Diagnostic Value of Serum CEA, CA-125, and ROMA Index in Low-Grade Serous Ovarian Cancer
- The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
- Trends of low-grade serous ovarian carcinoma in the United States
Pre-clinical Research
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas
- An immunophenotyping of Ovarian Cancer with Clinical and Immunological Significance
- CAISMOV24, a new human low-grade serous ovarian carcinoma cell line
- Connective tissue growth factor mediates TGF-β1-induced low-grade serous ovarian tumor cell apoptosis
- Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines
- Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
- EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas
- Extreme Outlier Analysis Identifies Occult Mitogen- Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer
- Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium
- Hormone receptor expression profile of low-grade serous ovarian cancers
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- Immunosuppressive microenvironment in low-grade serous ovarian carcinoma
- Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53- independent pathway
- Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
- Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer
- Loss of 1p36.33 Frequent in Low- Grade Serous Ovarian Cancer
- Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
- Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
- Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma
- MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
- Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma
- Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network
- Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer
- Tubal Origin of (Ovarian) Low-Grade Serous Carcinoma: A Gene Expression Profile Study
General research that may be of interest
- Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses
- Doctor, Does This Mean I’m Going to Starve to Death?
- Fasting, Starving Cancer (from The Lancet)
- Going to extremes: determinants of extraordinary response and survival in patients with cancer
- Pathology of borderline and invasive cancers
- Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model
- Prognostic indicators in ovarian serous borderline tumours
- Reduction/Prevention of Lower Extremity Lymphedema after Pelvic and Para-aortic Lymphadenectomy for Patients with Gynecologic Malignancies
Back to research and how to interpret it.